Study Site
Kitale, Trans Nzoia County, Kenya
5 recruiting
Showing 1–9 of 9 trials
Recruiting
Phase 3
A Study to Evaluate the Efficacy and Safety of Veverimer for the Treatment of Metabolic Acidosis
CKDMetabolic Acidosis
Renibus Therapeutics, Inc.150 enrolled21 locationsNCT07355062
Recruiting
Not Applicable
Promoting Mental Health of Teachers and Caregiver Using a Personalized mHealth Toolkit in Uganda
Depression, AnxietyMental Health Literacy
NYU Langone Health1,180 enrolled2 locationsNCT06087159
Recruiting
Phase 1Phase 2
A Study to Investigate ANS02 in Participants With EGFR Mutation-Positive Non-Small Cell Lung Cancer
Non-small Cell Lung Cancer
Avistone Biotechnology Co., Ltd.294 enrolled5 locationsNCT07538804
Recruiting
Phase 3
Study of Oral Deucrictibant XR Tablet for Prophylaxis and Deucrictibant IR Capsule for On-Demand Treatment of Angioedema Attacks in Adults With Acquired Angioedema Due to C1 Inhibitor Deficiency
Acquired Angioedema Due to C1-Inhibitor Deficiency (AAE-C1-INH)
Pharvaris Netherlands B.V.32 enrolled32 locationsNCT07266805
Recruiting
Phase 2
A Study to Evaluate Safety and Efficacy of TP-05 in Healthy Participants With Tick Exposure
Lyme Disease
Tarsus Pharmaceuticals, Inc.700 enrolled19 locationsNCT07562087
Recruiting
Phase 1
Safety and PK Study of BICX104 With or Without Bupropion Compared to Vivitrol
Healthy Adult Male and Female Volunteers
BioCorRx Pharmaceuticals Inc30 enrolled1 locationNCT07269873
Recruiting
Phase 3
Long-Term, Open-label Study of Oral Deucrictibant Extended-Release Tablet for Prophylaxis Against Angioedema Attacks in Adolescents and Adults With HAE
Hereditary Angioedema (HAE)
Pharvaris Netherlands B.V.170 enrolled62 locationsNCT06679881
Recruiting
Not Applicable
Peers and Technology for Adherence, Access, Accountability, and Analytics (PT4A)
HypertensionCardiovascular Disease
NYU Langone Health1,140 enrolled3 locationsNCT06485700
Recruiting
Phase 1
A Study of GZR4 Injection at Different Injection Sites
Healthy Subjects
Gan and Lee Pharmaceuticals, USA24 enrolled1 locationNCT06548906